Complications, Outcomes and Revisions Following Hiatal Hernia Repair With MIROMESH

NCT03735862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2019-10-01

Study results available
· View outcomes & findings →

Summary

Investigator will identify a consecutive cohort of patients who have undergone a hiatal hernia repair and are at least 6 months post index procedure.

Conditions

  • Hiatal Hernia With Gastroesophageal Reflux Disease
  • Gastroesophageal Reflux
  • GERD

Interventions

BIOLOGICAL

Hepatic derived surgical matrix

Hiatal hernia repair with MIROMESH

Sponsors & Collaborators

  • Miromatrix Medical Inc.

    lead INDUSTRY

Principal Investigators

  • George K Gillian, M.D. · Virginia Heartburn and Hernia Institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-06-01
Completion
2018-10-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03735862 on ClinicalTrials.gov